延迟随访与青光眼视野进展的关联研究
该回顾性队列与匹配病例对照研究纳入600例青光眼患者及疑似者的1121只眼,分析延迟随访(DFU)与Humphrey视野(HVF)进展的关联。多变量分析中DFU各项指标与HVF进展无显著关联,但在基线MD≤-6 dB患者的匹配分析中,平均DFU>60天与HVF进展风险升高相关。结论提示对多数青光眼患者,较长随访间隔可能与视野进展无关。
要点
- DFU占所有随访的53.4%,多变量分析中DFU与HVF进展无显著关联。
- 基线MD≤-6 dB患者中,平均DFU>60天与HVF进展风险升高相关(aOR 1.95)。
- 高龄、大杯盘比、较短随访时长、较多HVF次数及未满足社会需求与进展风险升高相关。
核心结论
- 对多数青光眼患者,长于当前推荐间隔的随访可能与视野进展无关。
研究设计与样本
- 回顾性队列与匹配病例对照研究,纳入三级中心600例患者共1121只眼,2014至2023年间至少5次HVF检查。
主要发现
- 基线MD>-6 dB眼HVF进展占19.8%,基线MD≤-6 dB眼占32.8%。
- DFU占所有随访的53.4%。
- 多变量分析中DFU百分比、平均DFU天数及最大DFU天数均与HVF进展无关联。
- 匹配病例对照分析中,基线MD≤-6 dB患者平均DFU>60天较≤30天与HVF进展风险升高相关(aOR 1.95;95%CI 1.03-3.68)。
- 最大DFU>365天较≤120天呈边缘关联(aOR 1.77;95%CI 0.97-3.23)。
关键数值与推荐
- HVF进展定义为所有检查的MD线性回归斜率≤-0.5 dB/年。
- DFU定义为超过提供者推荐随访间隔,量化为DFU就诊百分比、平均DFU天数及最大DFU天数。
临床怎么用
- 对多数青光眼患者,适当延长随访间隔可能不增加视野进展风险,但基线MD≤-6 dB者平均DFU>60天需警惕进展风险升高。
局限性
- 原文未报告具体局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To query current practice for glaucoma follow-up intervals by studying the association between delayed follow-up (DFU) and glaucoma progression. DESIGN: Retrospective cohort and matched case-control study. SUBJECTS: Glaucoma patients and suspects at a tertiary care center. METHODS: Electronic health record and Humphrey Visual Field (HVF) data were collected for patients with at ≥5 HVF tests between 2014 and 2023. DFU was defined as exceeding provider-recommended intervals and quantified for each participant as the percentage of visits with DFU, mean days of DFU, and maximum days of DFU. Associations between DFU metrics and HVF progression were analyzed using covariate adjusted multivariable logistic regression models. Subgroup analyses by baseline mean deviation (MD) and a sensitivity analysis of patients with 2 or more HVF tests with case-control matching (age, follow-up duration, number of HVF tests, and baseline MD) were performed. MAIN OUTCOME MEASURES: HVF progression: MD linear regression slope ≤-0.5 dB/year across all tests. RESULTS: A total of 1121 eyes from 600 patients were included (mean follow-up: 7.3 years; mean baseline age: 73.7 years; 50.2% female). HVF progression occurred in 19.8% of eyes with baseline MD >-6 dB and 32.8% with baseline MD ≤-6 dB. Any DFU occurred in 53.4% of all visits. In multivariable analyses, percentage of visits with DFU, mean days of DFU, and maximum days of DFU were not associated with HVF progression, including in subgroup analyses. Older age, larger cup to disc ratio, shorter follow-up duration, higher number of HVF tests, and unmet social needs were associated with higher odds of HVF progression (all P < .05). In the matched case-control analysis, a mean DFU of >60 days was significantly associated with higher odds of HVF progression (aOR: 1.95; 95% CI: 1.03-3.68, compared to ≤30 days), and a maximum DFU of >365 days showed a borderline association (aOR: 1.77; 95% CI: 0.97-3.23, compared to ≤120 days) among patients with baseline MD <-6 dB. CONCLUSION: These findings suggest that longer follow-up intervals than those currently prescribed may not be associated with VF progression for most glaucoma patients.
引用
- Kolli A, Chen E, Xu X, et al. Visual Field Progression in Glaucoma Patients With Delayed Follow-Up. Am J Ophthalmol. 2026. PMID: 42134617. doi:10.1016/j.ajo.2026.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。